{"id":559824,"date":"2024-12-08T17:11:06","date_gmt":"2024-12-09T01:11:06","guid":{"rendered":"https:\/\/nai500.com\/blog\/2024\/12\/%e6%9d%bf%e5%9d%97%e5%b7%ae%e4%b8%8d%e4%bb%a3%e8%a1%a8%e4%b8%aa%e8%82%a1%e5%b7%ae%ef%bc%8c%e6%af%94%e5%a6%82%e8%af%b4%e8%bf%99%e4%b8%a4%e5%8f%aa%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e8%82%a1%e7%a5%a8\/"},"modified":"2024-12-08T17:11:45","modified_gmt":"2024-12-09T01:11:45","slug":"%e6%9d%bf%e5%a1%8a%e5%b7%ae%e4%b8%8d%e4%bb%a3%e8%a1%a8%e5%80%8b%e8%82%a1%e5%b7%ae%ef%bc%8c%e6%af%94%e5%a6%82%e8%aa%aa%e9%80%99%e5%85%a9%e9%9a%bb%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e8%82%a1%e7%a5%a8","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2024\/12\/%e6%9d%bf%e5%a1%8a%e5%b7%ae%e4%b8%8d%e4%bb%a3%e8%a1%a8%e5%80%8b%e8%82%a1%e5%b7%ae%ef%bc%8c%e6%af%94%e5%a6%82%e8%aa%aa%e9%80%99%e5%85%a9%e9%9a%bb%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e8%82%a1%e7%a5%a8\/","title":{"rendered":"\u677f\u584a\u5dee\u4e0d\u4ee3\u8868\u500b\u80a1\u5dee\uff0c\u6bd4\u5982\u8aaa\u9019\u5169\u96bb\u751f\u7269\u79d1\u6280\u80a1\u7968"},"content":{"rendered":"<p>2024\u5e74\u4ee5\u4f86\uff0c\u751f\u7269\u79d1\u6280\u884c\u696d\u6574\u9ad4\u8868\u73fe\u843d\u5f8c\u65bc\u5e02\u5834\u3002\u7f8e\u80a1\u751f\u7269\u79d1\u6280\u4ea4\u6613\u6240\u4ea4\u6613\u57fa\u91d1\uff08ETF\uff09SPDR S&amp;P Biotech ETF\u4eca\u5e74\u4e0a\u6f32\u4e869%\uff0c\u540c\u671f\u6a19\u666e500\u6307\u6578\u4e0a\u6f3228%\u3002\u9019\u7a2e\u8da8\u52e2\u662f\u5426\u6703\u5ef6\u7e8c\u81f32025\u5e74\u5c1a\u96e3\u9810\u6e2c\uff0c\u4f46\u500b\u5225\u751f\u7269\u79d1\u6280\u80a1\u7968\u7684\u9577\u671f\u589e\u9577\u524d\u666f\u4f9d\u7136\u503c\u5f97\u95dc\u6ce8\u3002<\/p>\n<p>\u6bd4\u5982\u8aaa\uff0c<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=CRSP\">CRISPR Therapeutics\uff08NASDAQ: CRSP\uff09<\/a>\u548cExelixis\uff08NASDAQ: EXEL\uff09\u662f\u76ee\u524d\u503c\u5f97\u95dc\u6ce8\u7684\u5169\u96bb\u751f\u7269\u79d1\u6280\u80a1\u7968\u3002\u5118\u7ba1\u4eca\u5e74\u9019\u5169\u5bb6\u516c\u53f8\u80a1\u50f9\u8868\u73fe\u8fe5\u7570\u2014\u2014CRISPR Therapeutics\u4f4e\u8ff7\uff0c\u800cExelixis\u5927\u5e45\u8dd1\u8d0f\u5e02\u5834\u2014\u2014\u4f46\u5b83\u5011\u90fd\u64c1\u6709\u4ee4\u4eba\u671f\u5f85\u7684\u524d\u666f\u3002<\/p>\n<p>\u4ee5\u4e0b\u662f\u8a73\u7d30\u89e3\u6790\uff1a<\/p>\n<h2>1. CRISPR Therapeutics\uff08\u57fa\u56e0\u7de8\u8f2f\u9818\u57df\u7684\u5148\u92d2\uff09<\/h2>\n<p>CRISPR Therapeutics\u662f\u4e00\u5bb6\u5c08\u6ce8\u4e8e\u57fa\u56e0\u7de8\u8f2f\u6280\u8853\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u4ee5\u958b\u767c\u51fa\u5168\u7403\u9996\u500b\u5229\u7528\u8afe\u8c9d\u723e\u7372\u734e\u6280\u8853CRISPR\u7684\u7372\u6279\u85e5\u7269Casgevy\u800c\u805e\u540d\u3002\u8a72\u85e5\u7269\u7684\u7814\u767c\u5408\u4f5c\u5925\u4f34\u662fVertex Pharmaceuticals\u3002<\/p>\n<p>Casgevy\u65bc2023\u5e7411\u6708\u9996\u6b21\u7372\u6279\uff0c\u7528\u65bc\u6cbb\u7642\u5169\u7a2e\u7f55\u898b\u7684\u8840\u6db2\u76f8\u95dc\u75be\u75c5\uff1a\u8f38\u8840\u4f9d\u8cf4\u6027\u03b2-\u5730\u4e2d\u6d77\u8ca7\u8840\uff08TDT\uff09\u548c\u942e\u72c0\u7d30\u80de\u75c5\uff08SCD\uff09\u3002\u76ee\u524d\u9019\u5169\u7a2e\u75be\u75c5\u7684\u6cbb\u7642\u9078\u64c7\u975e\u5e38\u6709\u9650\uff0c\u56e0\u6b64Casgevy\u6f5b\u5728\u7684\u5e02\u5834\u7a7a\u9593\u975e\u5e38\u5927\u3002\u7121\u8ad6\u662f\u5728\u7f8e\u570b\uff0c\u9084\u662f\u5728\u6b50\u6d32\u3001\u6c99\u7279\u963f\u62c9\u4f2f\u548c\u5df4\u6797\u7b49\u5730\u5340\uff0c\u8a72\u516c\u53f8\u5e7e\u4e4e\u6c92\u6709\u7af6\u722d\u5c0d\u624b\u3002\u5047\u8a2d\u6cbb\u7642\u60a3\u8005\u4eba\u6578\u70ba2\u842c\uff08\u76ee\u6a19\u5e02\u5834\u60a3\u8005\u4eba\u6578\u7d04\u70ba5.8\u842c\uff09\uff0c\u6309\u5e73\u5747\u6bcf\u4f8b\u6cbb\u7642\u8cbb\u7528150\u842c\u7f8e\u5143\uff08\u7f8e\u570b220\u842c\u7f8e\u5143\uff09\u8a08\u7b97\uff0c\u8a72\u85e5\u7269\u7684\u5e02\u5834\u898f\u6a21\u6216\u9ad8\u9054300\u5104\u7f8e\u5143\u3002<\/p>\n<ul>\n<li>\u73fe\u72c0\u8207\u6311\u6230<br \/>\n\u5118\u7ba1\u5177\u5099\u5de8\u5927\u6f5b\u529b\uff0c\u4f46\u7531\u65bc\u5be6\u65bd\u57fa\u56e0\u7de8\u8f2f\u7642\u6cd5\u7684\u8907\u96dc\u6027\uff0cCasgevy\u81f3\u4eca\u5c1a\u672a\u70ba\u516c\u53f8\u8ca2\u737b\u6536\u5165\u3002\u6b64\u5916\uff0cCRISPR Therapeutics\u76ee\u524d\u4ecd\u8655\u65bc\u8667\u640d\u72c0\u614b\uff0c\u9019\u5728\u4e2d\u5c0f\u578b\u751f\u7269\u79d1\u6280\u516c\u53f8\u4e2d\u96d6\u5c6c\u5e38\u898b\uff0c\u4f46\u8fd1\u5e74\u4f86\u6295\u8cc7\u8005\u5c0d\u8667\u640d\u4f01\u696d\u7684\u8010\u5fc3\u8b8a\u5c11\uff0c\u5c0e\u81f4\u516c\u53f8\u80a1\u50f9\u8868\u73fe\u4e0d\u4f73\u3002<\/li>\n<li>\u516c\u53f8\u8ca1\u52d9\u8207\u524d\u666f<br \/>\n\u5118\u7ba1\u5b58\u5728\u77ed\u671f\u56f0\u5883\uff0cCRISPR Therapeutics\u4e26\u4e0d\u7f3a\u4e4f\u8cc7\u91d1\u652f\u6301\u30022023\u5e74\u7b2c\u4e09\u5b63\u5ea6\u672b\uff0c\u516c\u53f8\u64c1\u670919\u5104\u7f8e\u5143\u7684\u73fe\u91d1\u5132\u5099\u3002\u6b64\u5916\uff0c\u516c\u53f8\u9084\u6709\u591a\u500b\u8655\u65bc1\u671f\u548c2\u671f\u81e8\u5e8a\u8a66\u9a57\u968e\u6bb5\u7684\u57fa\u56e0\u7de8\u8f2f\u5019\u9078\u85e5\u7269\uff0c\u6709\u671b\u5728\u672a\u4f86\u53d6\u5f97\u7a81\u7834\u3002<\/li>\n<\/ul>\n<p>\u6295\u8cc7CRISPR Therapeutics\u9700\u8981\u8010\u5fc3\uff0c\u4f46\u96a8\u8457Casgevy\u9010\u6b65\u6253\u958b\u5e02\u5834\uff0c\u52a0\u4e4b\u516c\u53f8\u5f37\u5927\u7684\u5275\u65b0\u80fd\u529b\u548c\u8c50\u5bcc\u7684\u7814\u767c\u7ba1\u7dda\uff0c\u9577\u671f\u524d\u666f\u4e0d\u5bb9\u5ffd\u8996\u3002\u5c0d\u65bc\u770b\u597d\u57fa\u56e0\u7de8\u8f2f\u9818\u57df\u672a\u4f86\u7684\u6295\u8cc7\u8005\uff0c\u9019\u662f\u4e00\u96bb\u503c\u5f97\u8003\u616e\u7684\u80a1\u7968\u3002<\/p>\n<h2>2. Exelixis\uff08\u6297\u764c\u85e5\u9818\u57df\u7684\u7a69\u5065\u9818\u8dd1\u8005\uff09<\/h2>\n<p>Exelixis\u4eca\u5e74\u80a1\u50f9\u8868\u73fe\u5f37\u52c1\uff0c\u5176\u539f\u56e0\u4e4b\u4e00\u662f\u8a72\u516c\u53f8\u5728\u85e5\u54c1\u5c08\u5229\u9818\u57df\u53d6\u5f97\u4e86\u91cd\u5927\u9032\u5c55\u3002\u901a\u904e\u76f8\u95dc\u8a34\u8a1f\uff0c\u516c\u53f8\u6210\u529f\u963b\u6b62\u4e86\u6838\u5fc3\u6297\u764c\u85e5\u7269Cabometyx\u7684\u4eff\u88fd\u85e5\u9032\u5165\u5e02\u5834\uff0c\u5e02\u5834\u7368\u4f54\u5730\u4f4d\u5ef6\u7e8c\u81f32030\u5e74\u3002<\/p>\n<ul>\n<li>Cabometyx\u7684\u5e02\u5834\u8868\u73fe<br \/>\nCabometyx\u662fExelixis\u6700\u91cd\u8981\u7684\u7522\u54c1\uff0c\u7528\u65bc\u6cbb\u7642\u809d\u764c\u548c\u814e\u764c\u7b49\u75be\u75c5\u3002\u81ea\u4e0a\u5e02\u4ee5\u4f86\uff0c\u8a72\u6cbb\u7642\u65b9\u6848\u4e0d\u65b7\u64f4\u5927\u65b0\u7684\u9069\u61c9\u75c7\uff0c\u540c\u6642\u7dad\u6301\u5728\u67d0\u4e9b\u5e02\u5834\u4e0a\u7684\u9996\u9078\u7642\u6cd5\u3002\u516c\u53f8\u6b63\u5728\u7b49\u5f85Cabometyx\u6cbb\u7642\u80f0\u817a\u795e\u7d93\u5167\u5206\u6ccc\u816b\u7624\uff08pNET\uff09\u9019\u4e00\u65b0\u9069\u61c9\u75c7\u7684\u6279\u51c6\u3002\u5728\u76f8\u95dc\u76843\u671f\u81e8\u5e8a\u8a66\u9a57\u4e2d\uff0c\u8a72\u85e5\u8868\u73fe\u512a\u7570\uff0c\u8a66\u9a57\u4e2d\u671f\u5206\u6790\u5f8c\uff0c\u7368\u7acb\u76e3\u5bdf\u59d4\u54e1\u6703\u5efa\u8b70\u63d0\u524d\u7d50\u675f\u8a66\u9a57\uff0c\u8868\u660e\u9069\u61c9\u75c7\u64f4\u5145\u7684\u53ef\u80fd\u6027\u6975\u9ad8\u3002<\/li>\n<li>\u8ca1\u52d9\u8868\u73fe\u8207\u672a\u4f86\u898f\u5283<br \/>\n\u7b2c\u4e09\u5b63\u5ea6\uff0cExelixis\u7684\u6536\u5165\u540c\u6bd4\u589e\u957714%\uff0c\u9054\u52305.395\u5104\u7f8e\u5143\u3002\u540c\u6642\uff0c\u8abf\u6574\u5f8c\u6bcf\u80a1\u6536\u76ca\u90540.47\u7f8e\u5143\uff0c\u9060\u9ad8\u65bc\u4e0a\u5e74\u540c\u671f\u76840.10\u7f8e\u5143\u3002\u9019\u5145\u5206\u986f\u793a\u4e86\u516c\u53f8\u7684\u76c8\u5229\u80fd\u529b\u548c\u7a69\u5065\u7684\u696d\u52d9\u589e\u9577\u3002<\/li>\n<\/ul>\n<p>\u6b64\u5916\uff0cExelixis\u6b63\u5728\u958b\u767c\u5176\u4ed6\u6297\u764c\u85e5\u7269\uff0c\u5176\u4e2d\u5305\u62ec\u591a\u500b3\u671f\u81e8\u5e8a\u8a66\u9a57\u968e\u6bb5\u7684\u65b0\u85e5\u7269zanzalintinib\uff0c\u9810\u8a08\u5c07\u5ef6\u7e8cCabometyx\u7684\u5e02\u5834\u6210\u529f\u8def\u5f91\u3002\u540c\u6642\uff0c\u516c\u53f8\u4e5f\u5728\u63a8\u9032\u591a\u500b\u65e9\u671f\u7814\u767c\u9805\u76ee\uff0c\u70ba\u672a\u4f86\u9577\u671f\u589e\u9577\u63d0\u4f9b\u4fdd\u969c\u3002<\/p>\n<p>\u5118\u7ba1Exelixis\u7684\u80a1\u50f9\u4eca\u5e74\u5df2\u7d93\u5927\u5e45\u4e0a\u6f32\uff0c\u4f46\u6191\u85c9\u5176\u5f37\u52c1\u7684\u6536\u5165\u589e\u9577\u3001\u624e\u5be6\u7684\u7814\u767c\u6295\u5165\u4ee5\u53ca\u6e05\u6670\u7684\u767c\u5c55\u898f\u5283\uff0c\u672a\u4f86\u4ecd\u6709\u5de8\u5927\u589e\u9577\u7a7a\u9593\u3002<\/p>\n<h2>\u7e3d\u7d50<\/h2>\n<p>\u7e3d\u7684\u4f86\u8aaa\uff0cCRISPR Therapeutics\u548cExelixis\u5404\u5177\u7279\u8272\uff0c\u4e00\u500b\u4ee3\u8868\u8457\u57fa\u56e0\u7de8\u8f2f\u6280\u8853\u7684\u672a\u4f86\u7a81\u7834\uff0c\u4e00\u500b\u5247\u5728\u6297\u764c\u85e5\u9818\u57df\u6a39\u7acb\u4e86\u7a69\u5065\u589e\u9577\u7684\u5178\u7bc4\u3002\u6295\u8cc7\u9019\u5169\u96bb\u80a1\u7968\u4e0d\u50c5\u662f\u5c0d\u751f\u7269\u79d1\u6280\u884c\u696d\u672a\u4f86\u767c\u5c55\u524d\u666f\u7684\u62bc\u6ce8\uff0c\u4e5f\u6709\u671b\u5e36\u4f86\u9577\u671f\u7684\u8c50\u539a\u56de\u5831\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2024\u5e74\u4ee5\u4f86\uff0c\u751f\u7269\u79d1\u6280\u884c\u696d\u6574\u9ad4\u8868\u73fe\u843d\u5f8c\u65bc\u5e02\u5834\u3002\u7f8e\u80a1\u751f\u7269\u79d1\u6280\u4ea4\u6613\u6240\u4ea4\u6613\u57fa\u91d1\uff08ETF\uff09SPDR S&amp;P  [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":488767,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1522,431],"tags":[809,927,2233,564],"class_list":["post-559824","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1522","category-trends-strategies-zh-hant","tag-809","tag-927","tag-2233","tag-564","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/559824","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=559824"}],"version-history":[{"count":3,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/559824\/revisions"}],"predecessor-version":[{"id":559827,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/559824\/revisions\/559827"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/488767"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=559824"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=559824"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=559824"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}